Oxford Nanopore Technologies plc, the company delivering a new generation of molecular sensing technology based on nanopores, has reported that its Life Sciences Research Tools (LSRT) revenue for the six months ended 30 June 2023 was approximately £86 million, up from £70.6 million in the first half of last year.
This is a growth of around 22 per cent on a reported basis and 16 per cent on a constant currency basis.
Underlying LSRT revenue growth, excluding revenue from the Emirati Genome Program (EGP) and COVID-19 sequencing, is expected to be approximately 46 per cent on a constant currency basis.
The company said that growth continues to be driven by expansion of the Group's customer base.
READ MORE: Oxford spin-out gets £96m of funding at launch
Gordon Sanghera, Chief Executive Officer, said: "We have delivered strong underlying revenue growth in the first half of 2023, as demand for our technology continues to grow from an increasingly broad and diverse base of customers. We have also made considerable progress positioning the business for future growth: launching a number of innovative new products and platform updates that provide users with higher accuracy and richer data than ever before; forming significant collaborations to open up new opportunities in clinical and applied markets; and investing to ensure we have the required levels of inventory to support the continued expansion of our customer base."
Bath-based Future plc, the publisher of specialist online and print magazines, said trading in its…
The university of Bristol was one of six organisations to receive a contract from the…
Oxford BioDynamics Plc is teaming up with researchers at King's College London in a bid…
More than a quarter of a million extra construction workers are needed in the UK…
Kent-based housebuilder Vistry revealed it was on track to deliver more than 10% growth in…
A Dorset-based company, which has developed ground-breaking technology to recycle plastic waste and turn it…